$10.50
+0 (+0%)
At Close: Feb 01, 2024
Tabula Rasa Sees Better Than Expected Q2 Sales, Just As Investor Calls For Removal Of Top Executives
09:17am, Thursday, 21'st Jul 2022
Tabula Rasa HealthCare Inc (NASDAQ: TRHC) expects Q2 sales of $72 – $73 million, exceeding the prior guidance range of $66 – $69 million and the consensus of $67.61 million. Gordon Tunstall, TRH
Implied Volatility Surging for Tabula Rasa HealthCare (TRHC) Stock Options
12:48pm, Wednesday, 08'th Jun 2022 Zacks Investment Research
Investors need to pay close attention to Tabula Rasa HealthCare (TRHC) stock based on the movements in the options market lately.
Why This Analyst Thinks Tabula Rasa's Divestiture Plans 'An Important Step'
06:18pm, Monday, 09'th May 2022 Benzinga
RBC Capital Markets believe that the market has been assigning little-to-no value to Tabula Rasa HealthCare Inc's (NASDAQ: TRHC) MedWise, which has been burning cash and clouding, a strong core PACE
4 Analysts Have This to Say About Tabula Rasa HealthCare
02:12pm, Monday, 09'th May 2022 Benzinga
Over the past 3 months, 4 analysts have published their opinion on Tabula Rasa HealthCare (NASDAQ:TRHC) stock. These analysts are typically employed by large Wall Street banks and tasked with understa
Tabula Rasa HealthCare's (TRHC) CEO Calvin Knowlton on Q1 2022 Results -Earnings Call Transcript
02:29pm, Friday, 06'th May 2022
Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC ) Q1 2022 Earnings Conference Call May 6, 2022 8:30 AM ET Company Participants Kevin Dill – Corporate Counsel Calvin Knowlton – Founder, Chairman and Chie
68 Biggest Movers From Friday
09:49am, Monday, 07'th Mar 2022 Benzinga
Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO ) shares jumped 101.8% to close at $40.77 on Friday after jumping 39% on Thursday. Mexco Energy Corporation (NYSE: MXC ) surged 84.5% to settle at $24.94 on continued momentum. Imperial Petroleum Inc. (NASDAQ: IMPP ) gained 53.6% to close at $3.38. VEON Ltd. (NASDAQ: VEON ) shares jumped 52.1% to close at $0.40 on Friday after dropping 41% on Thursday. Marine Petroleum Trust (NASDAQ: MARPS ) rose 35.3% to settle at $7.13 amid the Russia-Ukraine conflict, which has caused supply concerns. Origin Agritech Limited (NASDAQ: SEED ) gained 35.2% to close at $9.60. New Concept Energy, Inc. (NYSE: GBR ) surged 26.3% to settle at $3.80. Sweetgreen, Inc. (NYSE: SG ) jumped 25.4% to close at $26.78 after the company reported better-than-expected Q4 sales results and issued FY22 sales guidance above analyst estimates. Sidus Space, Inc. (NASDAQ: SIDU ) shares gained 22.1% to close at $5.48. Sidus Space reported a strategic partnership with Aitech Systems to support LizzeSat Constellation.
CVI, VEON and CISO among mid-day movers
05:39pm, Friday, 04'th Mar 2022 Seeking Alpha
Gainers: VEON (VEON) +62%.CVR Energy (CVI) +48%.Atreca BCEL +44%.Indonesia Energy INDO +43%.Sidus Space SIDU +27%.Sweetgreen SG +20%.Tabula Rasa HealthCare TRHC +19%.Nine Energy…
43 Stocks Moving In Friday''s Mid-Day Session
05:05pm, Friday, 04'th Mar 2022 Benzinga
Gainers VEON Ltd. (NASDAQ: VEON ) rose 45.6% to $0.3830 after dropping 41% on Thursday. Indonesia Energy Corporation Limited (NASDAQ: INDO ) shares climbed 45.2% to $29.33 after jumping 39% on Thursday. Molecular Data Inc. (NASDAQ: MKD ) rose 22.8% to $0.2111 after declining around 6% on Thursday. Statera Biopharma, Inc. (NASDAQ: STAB ) climbed 20.6% to $0.8801. Statera Biopharma recently submitted Phase 1 clinical trial protocol to the FDA for investigational treatment of long-haul COVID-19. Sidus Space, Inc. (NASDAQ: SIDU ) shares climbed 18.7% to $5.33. Sidus Space reported a strategic partnership with Aitech Systems to support LizzeSat Constellation. Sweetgreen, Inc. (NYSE: SG ) gained 18.3% to $25.25 after the company reported better-than-expected Q4 sales results and issued FY22 sales guidance above analyst estimates. Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC ) jumped 16.5% to $6.49. Tabula Rasa Healthcare recently reported better-than-expected Q4 sales results. Funko, Inc. (NASDAQ: FNKO ) rose 14.4% to $20.36 after the company reported better-than-expected Q4 adjusted EPS and sales results and issued FY22 adjusted EPS guidance above analyst estimates. agilon health, inc. (NYSE: AGL ) surged 11.6% to $21.47 after the company reported better-than-expected Q4 sales results and issued Q1 sales guidance above estimates.
Tabula Rasa HealthCare, Inc. (TRHC) CEO Calvin Knowlton on Q4 2021 Results - Earnings Call Transcript
06:57pm, Friday, 25'th Feb 2022 Seeking Alpha45 Stocks Moving In Friday''s Mid-Day Session
05:02pm, Friday, 25'th Feb 2022 Benzinga
Gainers KAR Auction Services, Inc. (NYSE: KAR ) shares climbed 39.2% to $19.05 after the company agreed to sell its ADESA U.S. physical auction business to Carvana for $2.2 billion. Guggenheim upgraded KAR Auction Services from Sell to Neutral. CarGurus, Inc. (NASDAQ: CARG ) shares jumped 38% to $44.51 after the company reported better-than-expected Q4 results. Cyren Ltd. (NASDAQ: CYRN ) shares jumped 37.9% to $6.55 after gaining around 119% on Thursday. Cyren regained compliance with Nasdaq listing requirements. Farfetch Limited (NYSE: FTCH ) gained 26.7% to $19.02 after the company reported better-than-expected Q4 EPS results. Universal Security Instruments, Inc. (NYSE: UUU ) jumped 23% to $3.6796 after the company reported a joint merger deal with Infinite Reality. Paramount Group, Inc. (NYSE: PGRE ) gained 22.2% to $11.35. BVK and Paramount Joint Venture acquired M&M''s World Flagship Store at 1600 Broadway for $191.5 million. Aerie Pharmaceuticals, Inc. (NASDAQ: AERI ) surged 21.3% to $7.16 as the company swung to a profit in the fourth quarter.
Tabula Rasa HealthCare, Inc. (TRHC) CEO Calvin Knowlton on Q4 2021 Results - Earnings Call Transcript
01:57pm, Friday, 25'th Feb 2022
Tabula Rasa HealthCare, Inc. (TRHC) CEO Calvin Knowlton on Q4 2021 Results - Earnings Call Transcript
Tabula Rasa HealthCare, Inc. 2022 Q4 - Results - Earnings Call Presentation
12:34pm, Friday, 25'th Feb 2022 Seeking AlphaTabula Rasa Healthcare (TRHC) Reports Q4 Loss, Tops Revenue Estimates
01:10am, Friday, 25'th Feb 2022 Zacks Investment Research
Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of -28.57% and 0.76%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the sto
Tabula Rasa HealthCare GAAP EPS of -$0.91 misses by $0.10, revenue of $85.7M beats by $0.47M
10:32pm, Thursday, 24'th Feb 2022 Seeking Alpha
Tabula Rasa HealthCare press release (TRHC): Q4 GAAP EPS of -$0.91 misses by $0.10.Revenue of $85.7M (+11.2% Y/Y) beats by $0.47M.
Tabula Rasa HealthCare Reports Fourth Quarter and Full Year 2021 Results
10:24pm, Thursday, 24'th Feb 2022 Benzinga
MOORESTOWN, N.J. , Feb. 24, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. ("TRHC") (NASDAQ: TRHC ), a leading healthcare technology company advancing the safe use of medications, today reported financial results for the fourth quarter and full year ended December 31, 2021 . "Our fourth quarter results represent solid execution with double-digit growth across three of our four major revenue streams. We have made material progress on the three strategic objectives we outlined in our third quarter earnings report, specifically, leadership changes, the further consideration of the sale of non-core assets, and transformational partnerships. We believe that the actions we are taking will position the company to deliver increased revenue growth, greater profitability and free cash flow in 2022 and beyond," said Calvin H. Knowlton , PhD, TRHC''s Chief Executive Officer, Chairman and Founder. Key Financial Results (in millions except percentages) Actual Year over year change Guidance Low Guidance High Three Months Ended December 31, 2021 Total revenue $ 85.7 11.2 % $ 84.0 $ 86.0 GAAP net loss (21.4) (30.2) % (19.8) (18.8) Non-GAAP Adjusted EBITDA 4.3 (8.6) % 4.0 5.0 Twelve Months Ended December 31, 2021 Total revenue 331.3 11.5 % 329.6 331.6 GAAP net loss (79.1) (2.4) % (77.5) (76.5) Non-GAAP Adjusted EBITDA 19.6 (9.9) % 19.3 20.3 Recent Developments and Management Addition Strategic Initiatives In an effort to drive greater future internal efficiencies and increased client satisfaction, we are undertaking a number of initiatives including: 1) the outsourcing of our IT infrastructure to Accenture; 2) a more favorable pharmacy benefit manager (PBM) rebate agreement within our Pharmastar operations; and 3) a newly signed business processing outsourcing (BPO) contract within our third-party administrative (TPA) services that will take effect in late February 2022 .
Sign In
Buy TRHC